Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about EGR: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
Knowledge base pages for this entity
| Target | Relation | Type | Str |
|---|---|---|---|
| Kupffer Cell Enhancers | regulates | mechanism | 0.90 |
| Kupffer cell enhancers | regulates | pathway | 0.90 |
| KUPFFER_CELLS | regulates | cell_type | 0.64 |
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| GWAS of plasma NfL in East Asian cohort | exploratory | Alzheimer's disease | 0.950 | 0.00 | human patients - East Asian co | proposed | N/A |
| GWAS of plasma pTau217 in East Asian cohort | exploratory | Alzheimer's disease | 0.950 | 0.00 | human patients - East Asian co | proposed | N/A |
| Dairy intake and dementia risk in Malmö Diet and Cancer cohort | clinical | Alzheimer's disease | 0.950 | 0.00 | Swedish community-based adults | proposed | N/A |
| GWAS of plasma pTau181 in East Asian cohort | exploratory | Alzheimer's disease | 0.950 | 0.00 | human patients - East Asian co | proposed | N/A |
| GWAS of plasma GFAP in East Asian cohort | exploratory | Alzheimer's disease | 0.950 | 0.00 | human patients - East Asian co | proposed | N/A |
| KEEPS Continuation: Long-term effects of menopausal hormone therapy on | clinical | Alzheimer's disease | 0.950 | 0.00 | recently menopausal women with | proposed | N/A |
| GWAS of composite biomarker score | exploratory | Alzheimer's disease | 0.900 | 0.00 | human patients - East Asian co | proposed | N/A |
| RBG treatment in ApoE-/- atherosclerosis mouse model | validation | atherosclerosis | 0.900 | 0.00 | ApoE-/- mice | proposed | N/A |
| Chi3l1 deletion effects on baseline glial activation in mice | validation | baseline neuroinflammation | 0.900 | 0.00 | Chi3l1 knockout mice | proposed | N/A |
| CHI3L1 variant association with AD progression in human patients | exploratory | Alzheimer's disease | 0.850 | 0.00 | human patients | proposed | N/A |
| s:** - Biochemical binding assays measuring PROTAC selectivity for APO | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $100,000 |
| Why Does Amyloid Removal Only Slow Decline 27%? — Mechanistic investig | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $7,100,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegenerat [PMID:37995685] | Litvinchuk A, Suh JH, Guo JL, Lin K, Dav | Neuron | 2024 | 1 |
| The cell biology of APOE in the brain. [PMID:37805344] | Windham IA, Cohen S | Trends Cell Biol | 2024 | 1 |
| The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegene [PMID:37957317] | Maxine R Nelson, Peng Liu, Ayushi Agrawa | Nature neuroscience | 2023 | 1 |
| APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therape [PMID:33340485] | Serrano-Pozo A, Das S, Hyman BT | Lancet Neurol | 2021 | 1 |
| Lysosome-targeting chimaeras for degradation of extracellular proteins. [PMID:32728216] | Banik SM, Pedram K, Wisnovsky S, Ahn G, | Nature | 2020 | 1 |
| Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. [PMID:31564456] | Long JM, Holtzman DM | Cell | 2019 | 1 |
| Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. [PMID:31367008] | Yamazaki Y, Zhao N, Caulfield TR, Liu CC | Nat Rev Neurol | 2019 | 1 |
| Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associate [PMID:41905188] | Cetindag AC, Schipke CG, Esselmann H, Kr | The journal of prevention of A | 2026 | 0 |
| Perioperative polygenic and APOE-based genetic risk assessment for neurocognitiv [PMID:40562635] | Thedim M, Hu J, Maher M, Wiener-Kronish | Br J Anaesth | 2026 | 0 |
| Increased genetic protection against Alzheimer's disease in centenarians. [PMID:40615639] | Bae H, Song Z, Ali A, Sasaki T, Tesi N e | Geroscience | 2026 | 0 |
| Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis [PMID:40771159] | Padilla CM, Lafyatis R, Gibson KF, Morse | Arthritis Care Res (Hoboken) | 2026 | 0 |
| Integrative machine learning approach to risk prediction for dementia and Alzhei [PMID:40864401] | Stern A, Linial M | Geroscience | 2026 | 0 |
| Adipose Tissue Macrophage-Derived Proplatelet Basic Protein Exacerbates Psoriasi [PMID:40886963] | Zhu L, Du L, Wu J, Ding D, Wang J et al. | J Invest Dermatol | 2026 | 0 |
| Restoration of p53 mRNA combined with BRD4 silencing by brain targeted nanocapsu [PMID:41101204] | Sang Y, Cao Y, Li S, Quan Y, Wang S et a | Biomaterials | 2026 | 0 |
| Targeting KAT8 alleviates vascular senescence by modulating the INHBA/TGF-β path [PMID:41445196] | Lin Z, Xiong J, Zhang F, Zhang H, Zhu M | Mol Ther | 2026 | 0 |
| Obstructive sleep apnea, biomarker profiles, and clinical progression in Parkins [PMID:41499940] | Zhu S, An D, Liu X | Sleep Med | 2026 | 0 |
| Menopause, cognition, and Alzheimer's disease risk. [PMID:41531227] | Samudra N, Vemuri M, Weitlauf J | Curr Opin Obstet Gynecol | 2026 | 0 |
| Peripheral cancer attenuates amyloid pathology in Alzheimer's disease via cystat [PMID:41576952] | Li X, Tang X, Zeng J, Duan L, Hou Z et a | Cell | 2026 | 0 |
| SuPAR levels are increased in sera of euthymic patients with bipolar disorder an [PMID:41605346] | Kök Kendirlioğlu B, Çörekli Kaymakçı E, | J Affect Disord | 2026 | 0 |
| Chitinase-like Proteins YKL-40 and YKL-39 in Colorectal Cancer. [PMID:41677627] | Ivanova T, Kazakova M, Dikov D, Dzhambov | Cells | 2026 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning EGR in their description or question text
Score: 0.730 · biomarkers · 2026-04-22
## Mechanistic Overview Integrated Multi-Analyte CSF Panel Combining YKL-40, sTREM2, and Neurogranin starts from the cla
Score: 0.706 · neuroinflammation · 2026-04-21
## Mechanistic Overview Autophagy-Lysosomal Degradation of IBA1 in Stressed Microglia starts from the claim that modulat
Score: 0.698 · neuroimmunology · 2026-04-15
## Mechanistic Overview Granzyme B Inhibition with Serpina3n to Preserve Axonal Integrity Against Cytotoxic Attack start
Score: 0.670 · synaptic biology · 2026-04-21
**Molecular Mechanism and Rationale** The P2Y12 purinergic receptor represents a critical molecular determinant of micr
Score: 0.663 · translational neuroscience · 2026-04-16
**Molecular Mechanism and Rationale** Choline kinase alpha (CHKA) represents a critical regulatory enzyme in phospholip
Score: 0.660 · neurodegeneration · 2026-04-22
**Molecular Mechanism and Rationale** The blood-brain barrier (BBB) represents a highly specialized neurovascular inter
Score: 0.653 · molecular biology · 2026-04-21
## Mechanistic Overview GDF15-GFRAL Axis as Systemic Autophagy-Senescence Integrator starts from the claim that modulati
Score: 0.638 · neurodegeneration · 2026-04-04
## Molecular Mechanism and Rationale The molecular foundation for acid-degradable lipid nanoparticle (ADP-LNP)-mediated
Score: 0.622 · neurodegeneration · 2026-04-21
## Mechanistic Overview TOM/TIM Complex Disruption Triggering Mitochondrial Integrated Stress Response (mtISR) starts fr
Score: 0.620 · protein folding · 2026-04-22
**Molecular Mechanism and Rationale** The chaperone-degradation coupling hypothesis centers on the critical interaction
Score: 0.580 · neuroinflammation · 2026-04-22
**Molecular Mechanism and Rationale** The αvβ3 integrin-FAK-SYK-CARD9/NF-κB pathway represents a novel mechanistic fram
Score: 0.580 · protein biochemistry · 2026-04-21
**Molecular Mechanism and Rationale** The carboxy terminus of Hsc70-interacting protein (CHIP, encoded by STUB1) functi
Score: 0.566 · neurodegeneration · 2026-04-22
## Mechanistic Overview Vascular and Perivascular Cell Type Vulnerability: BBB Integrity Disruption starts from the clai
Score: 0.564 · Alzheimer's disease · 2026-04-20
## Mechanistic Overview Closed-loop tACS targeting EC-II somatostatin interneurons to restore dendritic integration and
Score: 0.564 · Alzheimer's disease · 2026-04-20
## Mechanistic Overview Closed-loop transcranial focused ultrasound targeting entorhinal PV interneurons to restore Anky